TeachAde

Transplant Rejection and GvHD

Gene therapy is a rapidly developing field that presents previously unheard-of possibilities for the treatment of complicated illnesses. Despite advancements in transplantation, transplant rejection and GvHD remain significant hurdles, leading to patient morbidity and mortality. Current immunosuppressive regimens often lack specificity, resulting in broad immune suppression and associated side effects.